Webinar on COVID-19 and diabetes
Date
2020-04-30
Authors
Fasanmade, O.A
Journal Title
Journal ISSN
Volume Title
Publisher
Novo Nordisk
Abstract
About 10% of coronavirus-infected patients have diabetes as a comorbidity. It seems diabetes may not increase the risk of SARS-CoV-2 infection, but it promotes severe progression of disease in COVID-19 patients.
Diabetes promotes severe progression in COVID-19 patients. Diabetes comorbidity is associated with significantly increased mortality (0.9% mortality for patients without comorbidity vs. 7.3% mortality for patients with diabetes)
Diabetes with COVID-19 appears more blood glucose fluctuations, strengthen dynamic glucose monitoring is necessary Insulin IV injection should be the first-line treatment in severe and critical patients.
Description
Conference paper
Keywords
Diabetes mellitus, , COVID-19 , Management , Patients , Research Subject Categories::MEDICINE
Citation
Fasanmade OA. Webinar on COVID-19 and diabetes. 2020